Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin

International Immunology

Volumn 9, Issue 7, 1997, Pages 975-982

  Valentine, Janet E ^b   Sewell, William A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cytokine; IL 2 receptor; IL 5; T lymphocytes

Indexed keywords

CYCLOHEXIMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 5; MESSENGER RNA; PHYTOHEMAGGLUTININ; RAPAMYCIN; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4;

ARTICLE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CYCLOHEXIMIDE; CYCLOSPORINE; DRUG RESISTANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; PHYTOHEMAGGLUTININS; POLYENES; RECOMBINANT PROTEINS; RNA, MESSENGER; SIROLIMUS;

EID: 0030980222     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.7.975     Document Type: Article

References (50)

1. Smith, K. A. 1988. Interleukin-2: inception, impact and implications. Science 240:1169.
2. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
3. Oster, W., Lindemann, A., Mertelsmann, R. and Herrmann, F. 1989. Production of macrophage-, granulocyte-, granulocyte-macrophage- and multi-colony-stimulating factor by peripheral blood cells. Eur. J. Immunol. 19:543.
4. Kasahara, T., Hooks, J. J., Dougherty, S. F. and Oppenheim, J. J. 1983. Interleukin 2-mediated immune Interferon (IFNγ) production by human T cells and T cell subsets. J. Immunol. 130:1784.
5. Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A. and Goeddel, D. V. 1985. Effect of interleukin 2, interferon-γ, and mitogens on the production of tumor necrosis factors α and β. J. Immunol. 135:2492.
6. Bello-Fernandez, C., Bird, C., Heslop, H. E., Gottlieb, D. J., Reittie, J. E., Rill, D. M., Holland, M., Prentice, H. G. and Brenner, M. K. 1991. Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function. Blood 77:1283.
7. Enokihara, H., Furusawa, S., Nakakubo, H., Kajitani, H., Nagashima, S., Saito, K., Shishido, H., Hitoshi, Y., Takatsu, K., Noma, T., Shimizu, A. and Honjo, T. 1989. T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood 73:1809.
8. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E. and Leonard, W. J. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262:1880.
9. Paul, W. E. and Seder, R. A. 1994. Lymphocyte responses and cytokines. Cell 76:241.
10. Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G. and Vadas, M. A. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219.
11. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101.
12. Coffman, R. L., Seymour, B. W. P., Hudak, S., Jackson, J. and Rennick, D. 1989. Antibody to IL-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.
13. Foster, P. S., Hogan, S. P., Ramsay, A. J., Matthaei, K. I. and Young, I. G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med, 183:195.
14. Rolfe, F. G., Hughes, J. M., Armour, C. L. and Sewell, W. A. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77:494.
15. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449.
16. Van Straaten, J. F. M., Dokter, W. H. A., Stulp, B. K. and Vellenga, E. 1994. The regulation of interleukin 5 and interleukin 3 gene expression in human T cells. Cytokine 6:229.
17. van Haelst Pisani, C., Kovach, J. S., Kita, H., Leiferman, K. M., Gleich, G. J., Silver, J. E., Dennin, R. and Abrams, J. S. 1991. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 78:1538.
18. Macdonald, D., Gordon, A. A., Kajitani, H., Enokihara, H. and Barrett, A. J. 1990. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br. J. Haematol. 76:168.
19. Endo, H., Iwamoto, I., Nakajima, H. and Yoshida, S. 1993. In vitro interleukin-5 production of peripheral blood mononuclear cells is increased in patients with asthma. Int. Arch. Allergy Immunol 101:425.
20. Granelli-Piperno, A., Inaba, K. and Steinman, R. M. 1984. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J. Exp. Med. 160:1792.
21. Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R. and Sigal, N. H. 1990. Distinct mechanism of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144:251.
22. Sigal, N. H. and Dumont, F. J. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519.
23. Tocci, M. J., Matkovich, D. A., Collier, K. A., Kwok, P., Dumont, F., Lin, S., Degudicibus, S., Siekierka, J. J., Chin, J. and Hutchinson, N. I. 1989. The immunosupressant FK-506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143:718.
24. Hanke, J. H., Nichols, L. N. and Coon, M. E. 1992. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA. Lymphokine Cytokine Res. 11:221.
25. Foster, P. S., Hogan, S. P., Ramsay, A. J., Matthaei, K. I. and Young, I. G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
26. Lock, S. H., Kay, A. B. and Barnes, N. C. 1996. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Resp. Crit. Care Med. 153:509.
27. Haczku, A., Alexander, A., Brown, P., Assoufi, B., Li, B., Kay, A. B. and Corrigan, C. 1994. The effect of dexamethasone, cyclosporin, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93:510.
28. Chilson, O. P., Boylston, A. W. and Crumpton, M. J. 1984. Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor. EMBO J. 3:3239.
29. Weiss, A., Imboden, J., Shoback, D. and Stobo, J. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl Acad. Sci. USA 81:4169.
30. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156.
31. + subset of human T cells. Growth Factors 6:295.
32. Valentine, J. E., Boyle, M. J., Gough, N. M. and Sewell, W. A. 1992. Presence of single-stranded DNA in PCR products of slow electrophoretic mobility. Bio Techniques 13:222.
33. Bohjanen, P. R., Okajima, M. and Modes, R. J. 1990. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc. Natl Acad. Sci. USA 87:5283.
34. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H. and Kohler, G. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
35. Spits, H., Yssel, H., Takebe, Y., Arai, N., Yokota, T., Lee, F., Arai, K.-I., Banchereau, J. and de Vries, J. E. 1987. Recombinant interleukin 4 promoters the growth of human T cells. J. Immunol. 139:1142.
36. Liu, J., Farmer, J. D., Jr, Lane, W. S., Friedman, J., Weissman, I. and Schreiber, S. L. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807.
37. Flanagan, W. M., Corthesy, B., Bram, R. J. and Crabtree, G. R. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803.
38. Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L. and Crabtree, G. R. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760.
39. Rao, A. 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 15:274.
40. Mills, G. B., Cheung, R. K., Grinstein, S. and Gelfand, E. W. 1985. Interleukin 2-induced lymphocyte proliferation is independent of increases in cytosolic-free calcium concentrations. J. Immunol. 134:2431.
41. Dunn, D. E., Herold, K. C., Otten, G. R., Lancki, D. W., Gajewski. T., Vogel, S. N. and Fitch, F. W. 1987. Interleukin 2 and concanavalin A stimulate interferon-y production in a murine cytolytic T cell clone by different pathways. J. Immunol. 139:3942.
42. Kelso, A. and Gough, N. M. 1989. Differential inhibition by cyclosporin A reveals two pathways for activation by lymphokine synthesis in T cells. Growth Factors 1:165.
43. Miyazaki, T., Liu, Z. J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M. and Taniguchi, T. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc. and lck cooperate in hematopoietic cell proliferation. Cell 81:223.
44. Hou, J., Schindler, U., Henzel, W. J., Wong, S. C. and McKnight, S. L. 1995. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2:321.
45. Lin, J.-X., Migone, T.-S., Tsang, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S. and Leonard, W. J. 1995. The role of the shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
46. Ivashkiv, L. B. 1995. Cytokines and STATs: how can signals achieve specificity? Immunity 3:1.
47. Fujii, H., Nakagawa, Y., Schindler, U., Kawahara, A., Mori, H., Gouilleux, F., Groner, B., Ihle, J. N., Minami, Y, Miyazaki, T. and Taniguchi, T. 1995. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl Acad. Sci. USA 92:5482.
48. Gaffen, S. L., Lai, S. Y., Xu, W., Gouilleux, F., Groner, B., Goldsmith, M. A. and Greene, W. C. 1995. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DMA-binding activity. Proc. Natl Acad Sci. USA 92:7192.
49. Ivashkiv, L. B., Schmitt, E. M. and Castro, A. 1996. Inhibition of transcription factor Stat1 activity in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway. J. Immunol. 157:1415.
50. Beadling, C., Guschin, D., Witthuhn, B. A., Ziemiecki, A., Ihle, J. N., Kerr, I. M. and Cantrell, D. A. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and Interferon α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 13:5605.